Clinical Trial Update: Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer [Phase 1, Phase 2]

View source ↗

Summary

The document describes a Pfizer-sponsored clinical trial investigating PF-08634404 alone or in combination with Enfortumab Vedotin for urothelial cancer, curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Cancer
• Urothelial Carcinoma

Drugs mentioned

• Enfortumab Vedotin (enfortumab vedotin)
• PF-08634404

Snippet

Sponsor: Pfizer | Conditions: Urothelial Cancer, Advanced/Metastatic Urothelial Cancer | Phase 1, Phase 2 | Status: RECRUITING